RenalTransplant near Garden City, NY

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Caner Dinlenc, MD is an Urology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 32 years. Dr. Caner Dinlenc, MD is affiliated with Mount Sinai Hospital, Mount Sinai Brooklyn and Mount Sinai Queens.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Biography: Dustin J. Carpenter is an Assistant Professor of Surgery at Weill Cornell Medical College, Cornell University, and an Attending Transplant Surgeon at New York-Presbyterian/Weill Cornell Medical Center. He is a board-certified surgeon who specializes in liver, kidney, and pancreas transplantation, living donor liver and kidney transplant, laparoscopic donor nephrectomy, and general surgery. Dr. Carpenter has an extensive research background, and has numerous publications in journals such as Nature, Cell, Science Immunology, and the American Journal of Transplantation.Dr. Carpenter completed his fellowship training in Multi-Organ Transplantation and Hepatobiliary Surgery at New York-Presbyterian Hospital Columbia University and Weill Cornell Medical Centers. He also did his general surgery residency training at Columbia University, and spent two years as a post-doctoral research fellow in immunology at the Columbia Center for Translational Immunology. Dr. Carpenter received his M.D. from Saint Louis University School of Medicine with distinction in research, and also a masters degree in epidemiology from Columbia University's Mailman School of Public Health. Dr. Carpenter graduatedfrom the University of Illinois with a B.S. in Molecular and Cellular Biology.

Biography: Dr. Peter Liou is an Assistant Professor of Surgery at Columbia University and an Attending Transplant Surgeon at New York Presbyterian Hospital. He is board-certified in general surgery and received specialty training in abdominal transplant and hepatobiliary surgery. His practice interests focus on the surgical management of adults and children with liver and bile duct disease including those with liver failure, cirrhosis, bile duct and gallbladder disease, as well as those with benign and malignant liver tumors and cysts. He is skilled in minimally invasive surgery and trained to perform both laparoscopic and robotic surgery whenever possible. Dr. Liou received his Bachelor of Arts degree in Biochemistry and Music from Columbia College, and subsequently attended medical school at Columbia University's College of Physicians and Surgeons. He was the recipient of a Doris Duke Translational Research Grant under the mentorship of Dr. Jessica Kandel. Dr. Liou then completed his general surgical residency at New York Presbyterian / Columbia, while receiving additional clinical training in Intestinal/Multivisceral transplant and Adult ECMO with Drs. Tomoaki Kato and Matthew Bacchetta during that time. He then continued with a surgical fellowship in Abdominal Organ Transplantation and Hepatobiliary Surgery at New York Presbyterian Columbia and Weill Cornell. Committed to providing compassionate and the latest comprehensive care, Dr. Liou routinely collaborates with an elite team of world-class providers in liver disease to achieve optimal outcomes and treatment success. He is also interested in international medicine, having participated in surgical outreaches and exchanges in China, Kenya, Swaziland, and Tanzania.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.